The present teachings relate to a medical flexible needle assembly with improved performance, more particularly a jacketed medical flexible needle assembly with a locally delaminated or decoupled jacket.
There is in certain medical procedures, a generally flexible medical device or needle may be preferred over a generally rigid medical device or needle. For example, a generally flexible needle (or flexible portion of a needle assembly) may be preferred during needle insertion and needle steering in the anatomy. It is generally known, that the flexible portion can be created by scribing or etching cuts in or through the wall of the needle or by some other means. When a flexible needle is used, it is generally desirable to include a barrier or jacket over at least some portion of the flexible portion to allow for a vacuum to be maintained in the case where the cuts are all the way through the needle wall. But, it is also contemplated that it is desirable have a device that is durable and does not greatly restrict the function of the cuts. It is also contemplated that the entire assembly (e.g. needle and jacket) have a diameter as small as possible while maintaining as large an inside diameter as possible.
It may therefore be desirable to have a flexible jacketed needle that includes features that allow movement of the cuts (flexing of the needle assembly), without the loss of the benefits of the jacketing. It may be attractive to provide a flexible jacketed needle that can be mass-produced relatively inexpensively, that has a minimal number of parts, and that is durable and relatively small in diameter.
The present teachings relate generally to a flexible needle assembly with a protective jacketing disposed over at least a portion of the assembly. The jacketing selectively attached to the assembly in regions that allow for an optimal balance of properties, including flexibility, durability, and performance.
The teachings herein provide for a hollow medical flexible needle assembly 10, comprising: a needle portion 20 disposed at a distal end 12 of the assembly; a stiff portion 30 disposed at a proximal end 14 of the assembly; an flexible portion 40 disposed between and interconnecting the needle portion and the stiff portion, including a flex distal portion 42, a flex proximal portion 44, and a flex intermediate portion therebetween; and a jacket layer 50 disposed about the assembly 10 over at least part of the flexible portion 40; characterized in that the jacketing member 50 includes one or more coupled regions 60 and one or more decoupled region 70, wherein in at least one or more of the one or more coupled regions 60 are located proximally, distally, or both of at least a portion of the flexible portion 40.
The teachings may also include one or more of the following: at least one of the one or more coupled regions 60 are disposed entirely outside of the flexible portion 40; at least one of the one or more coupled regions 60 are disposed within the flexible portion 40; at least one of the one or more decoupled regions 70 are disposed within the flexible portion 40; at least one of the one or more decoupled regions 70 are at least disposed over a spiral cut feature 48 and at least laterally away from the cut by a predefined amount; a third coupled region 62 is disposed between the one or more coupled regions 60; the coupled region 62 is disposed in-between a spiral cut feature 48, the spiral flex feature disposed within the flexible portion 40.
The explanations and illustrations presented herein are intended to acquaint others skilled in the art with the invention, its principles, and its practical application. The specific embodiments of the present invention as set forth are not intended as being exhaustive or limiting of the invention. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. The disclosures of all articles and references, including patent applications and publications, are incorporated by reference for all purposes. Other combinations are also possible as will be gleaned from the following claims, which are also hereby incorporated by reference into this written description. The present teachings relate generally to a medical flexible needle assembly. Each physical element is described in more detail below.
Flexible Needle Assembly 10
It is contemplated that the medical flexible needle assembly 10, may include a number of functional segments, including but not limited to a needle portion 20; a stiff portion 30; a flexible portion 40; and a jacketing member 50 disposed about the assembly 10 over at least part of the flexible portion 40. The assembly 10 may be a single shaft (e.g. hypotube 18) covered in at least one portion by the jacket or may be an assembly of the functional segments (e.g. needle portion, stiff portion, and flexible portion) at least partially covered by the jacket, or any combination thereof.
It is contemplated that the needle portion 20 or tissue piercing portion generally is disposed at a distal end 12 of the assembly and has a point at one end (distal end) and is solid or hollow. For the sake of this disclosure, it is assumed that the proximal end of the needle portion ends at the distal end of the flexible portion. The needle portion 20 can be generally unitary to and contiguous to the assembly or may be a separate component that is added to the assembly. In a preferred embodiment, the needle portion is contiguous to at least the flexible portion, or in other words, comprised of the same shaft or hypotube 18.
It is contemplated that the stiff portion 30 is disposed at or near proximal end 14 of the assembly. For the sake of this disclosure, it is assumed that the distal end of the stiff portion ends at the proximal end of the flexible portion. The stiff portion 30 can be generally unitary to and contiguous to the assembly or may be a separate component that is added to the assembly. It may include or be attached to other components (e.g. a handle, a guide mechanism, or similar components). In a preferred embodiment, the stiff portion is contiguous to at least the flexible portion, or in other words, comprised of the same shaft.
It is contemplated that the flexible portion 40 is disposed between and interconnects the stiff portion and the needle portion. The flex portion may be comprised a tube that has one or more cuts 48 that are cut (e.g., machine or laser) or etched into it. The flexible portion having at least a flex distal portion 42 (e.g. last portion of the cut), a flex proximal portion 44 (e.g. first portion of the cut), and a flex intermediate portion therebetween. It may also be comprised of structures, e.g. locking features and flexibility reliefs, described in international patent application PCT/US2016/019682, incorporated by reference as it relates to the ability to flex the device.
In the case of a cut, and in a preferred embodiment, the cut may have a width or kerf “K”. This width K may range from about 0.01 mm to as much as about 1.0 mm. It is contemplated that the jacketing member 50 spans across the width and is not coupled to the hypotube 18 across the width in any of the embodiments.
Jacketing Member 50
The jacket member may function to protect portions of the flexible needle assembly (e.g. one or more of needle portion 20; a stiff portion 30; a flexible portion 40), and particularly to help maintain the functionality of the assembly 10 such as maintaining a vacuum and still allowing flexibility. The jacket may be made of flexible material, such as a metal, a plastic, a polymer, a material that is biocompatible, or any combination thereof. The jacket may provide support or integrity to the assembly so that the device can take and retain a sample. The jacket may also be an outer containment jacket that interfaces with the inner lumen of an endoscope or another delivery device (e.g. bronchoscope). It is contemplated for one of the potential purposes of the present invention that the jacket may function as a protective barrier for the external side (outside diameter “OD”) of the flexible needle assembly. It is of particular import to have the jacket form a barrier over the flexible portion, which for example may be less smooth due to the geometry created to allow for flexibility of the needle assembly, while providing a contiguous integrity for the tube (e.g. an air/liquid tight seal). It is contemplated that the jacketing should be as thin as possible while maintaining its beneficial attributes. In a preferred embodiment, the jacket may range in thickness from about 0.005 mm to about 0.25 mm depending upon the material choice and the desired properties.
It is believed that it is commonly known that it is desirable to have the jacketing member that remains completely intact and connected to the assembly during use, particularly to maintain a seal over the flexible portion. It is believed that typical jacketing used today in this application may be constructed of a heat shrinkable polymer that is coupled (e.g. bonded) to the needle assembly along its entire length. One such jacketfixed layer material that is known and commercially available is Pebax® 2533 SA 01 MED resin, by Arkema. Pebax® 2533 SA 01 MED resin is a thermoplastic elastomer made of flexible polyether and rigid polyamide. It is contemplated that other materials may be employed, such as Polyethylene terephthalate “PET”, Polyurethane “PU”, and/or Polytetrafluoroethylene “PTFE”.
Coupled and Uncoupled Regions 60, 70
The present invention is directed towards taking the jacketing 50 and providing for selective coupled and uncoupled regions (60,70) that allow for the movement of the cuts (flexing of the needle assembly), without the loss of the benefits of the jacketing. Surprisingly, by providing select decoupled regions, the functionality (e.g. flexibility, durability, maintaining vacuum) of the assembly can be optimized. It is believed that utilizing select decoupled regions may allow for lower stresses in the jacketing and greater stretching when the assembly is flexed. It is believed that this can increase the durability of the assembly and prevent rupture of the jacketing. This increase in decoupled region length also may reduce stiffness in the laser cut section and may allow increased angulation in the endoscope or bronchoscope.
In an illustrative example of an assembly without selective decoupling, shown in
It is contemplated in a preferred embodiment, the jacketing member 50 includes one or more coupled regions 60 and one or more decoupled region 70, wherein in at least one or more of the one or more coupled regions 60 are located proximally, distally, or both of at least a portion of the flexible portion 40. In other preferred embodiments, one or more may be true: wherein at least one of the one or more coupled regions 60 are disposed entirely outside of the flexible portion 40; at least one of the one or more coupled regions 60 are disposed within the flexible portion 40; at least one of the one or more decoupled regions 70 are disposed within the flexible portion 40; at least one of the one or more decoupled regions 70 are at least disposed over a cut (e.g. spiral cut feature) 48 and at least laterally away from the cut; a third coupled region 62 is disposed between the one or more coupled regions 60; the coupled region 62 is disposed in-between a spiral cut feature 48, the spiral flex feature disposed within the flexible portion 40.
It is contemplated that a number of methods and techniques may be utilized to enable the creation of selectively decoupled regions. In one example, an additional material may be introduced to the OD of the hypotube 18 in areas where a decoupled region is desired. For example, an expanded PTFE (i.e., ePTFE) film or a layer of inadhesive material could be placed between the hypotube 18 and the longitudinally-fixed layer to prevent adhesion during the heat shrink-wrapping process. Another contemplated method to enable the creation of selectively decoupled regions includes selective heating of the jacketing. It is contemplated that shrinking heat is only applied in areas where coupling is desired. Areas which does not receive sufficient heat to shrink the jacket would remain uncoupled.
It is also contemplated that it may be desirable to have areas or regions that have enhanced coupling between the hypotube 18 and the jacket. It is possible to enhance adhesion or coupling by the use of additional adhesive materials between the hypotube 18 and jacketing. It is also possible to provide additional mechanical joining enhancements such as surface roughness or grain on the metal hypotube 18.
Illustrative Examples
Illustrative examples may be seen in
Unless otherwise stated, any test method standard referenced herein is for the version existing as of the earliest filing date in which the standard is recited.
Unless otherwise stated, all ranges include both endpoints and all numbers between the endpoints. The use of “about” or “approximately” in connection with a range applies to both ends of the range. Thus, “about 20 to 30” is intended to cover “about 20 to about 30”, inclusive of at least the specified endpoints.
The disclosures of all articles and references, including patent applications and publications, are incorporated by reference for all purposes. The term “consisting essentially of” to describe a combination shall include the elements, ingredients, components or steps identified, and such other elements ingredients, components or steps that do not materially affect the basic and novel characteristics of the combination. The use of the terms “comprising” or “including” to describe combinations of elements, ingredients, components or steps herein also contemplates embodiments that consist essentially of, or even consist of the elements, ingredients, components or steps. Plural elements, ingredients, components or steps can be provided by a single integrated element, ingredient, component or step. Alternatively, a single integrated element, ingredient, component or step might be divided into separate plural elements, ingredients, components or steps. The disclosure of “a” or “one” to describe an element, ingredient, component or step is not intended to foreclose additional elements, ingredients, components or steps. Moreover, unless expressly set forth, the recitation of “first”, “second”, or the like does not preclude additional ingredients, steps, or other elements. All references herein to elements or metals belonging to a certain Group refer to the Periodic Table of the Elements published and copyrighted by CRC Press, Inc., 1989. Any reference to the Group or Groups shall be to the Group or Groups as reflected in this Periodic Table of the Elements using the IUPAC system for numbering groups. It is understood that the above description is intended to be illustrative and not restrictive.
Many embodiments as well as many applications besides the examples provided will be apparent to those of skill in the art upon reading the above description. The scope of the invention should, therefore, be determined not with reference to the above description, but should instead be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. The disclosures of all articles and references, including patent applications and publications, are incorporated by reference for all purposes. The omission in the following claims of any aspect of subject matter that is disclosed herein is not a disclaimer of such subject matter, nor should it be regarded that the inventors did not consider such subject matter to be part of the disclosed inventive subject matter.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2017/018787 | 2/22/2017 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/156107 | 8/30/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5346502 | Estabrook | Sep 1994 | A |
5617874 | Baran | Apr 1997 | A |
7540875 | Jessen | Jun 2009 | B2 |
20040073162 | Bleam | Apr 2004 | A1 |
20050043682 | Kucklick et al. | Feb 2005 | A1 |
20110093007 | Abbott | Apr 2011 | A1 |
20110196410 | Besselink | Aug 2011 | A1 |
20120109130 | Casey | May 2012 | A1 |
20130006144 | Clancy | Jan 2013 | A1 |
20130225997 | Dillard | Aug 2013 | A1 |
20140276051 | Hoffman | Sep 2014 | A1 |
20160153719 | Tokuda et al. | Jun 2016 | A1 |
20160279388 | Barrish et al. | Sep 2016 | A1 |
20180064908 | Shuman | Mar 2018 | A1 |
Number | Date | Country |
---|---|---|
101816578 | Sep 2010 | CN |
103153201 | Jun 2013 | CN |
105377324 | Mar 2016 | CN |
105496552 | Apr 2016 | CN |
105813680 | Jul 2016 | CN |
105979880 | Sep 2016 | CN |
110430829 | Nov 2019 | CN |
0546712 | Jun 1993 | EP |
3568094 | Nov 2019 | EP |
3568094 | Apr 2022 | EP |
2004351005 | Dec 2004 | JP |
2008005965 | Jan 2008 | JP |
2013503693 | Feb 2013 | JP |
2020508162 | Mar 2020 | JP |
6901582 | Jun 2021 | JP |
2004030740 | Apr 2004 | WO |
2014080421 | May 2014 | WO |
2016153719 | Sep 2016 | WO |
WO-2018156107 | Aug 2018 | WO |
Entry |
---|
International Search Report, PCT/2017/018787, dated Oct. 26, 2017. |
“Chinese Application Serial No. 201780087028.5, Response filed Mar. 29, 2022 to Office Action dated Dec. 16, 2021”, with English claims and machine translation, 10 pgs. |
“Chinese Application Serial No. 201780087028.5, Office Action dated May 9, 2022”, with English translation of claims, 15 pgs. |
“Chinese Application Serial No. 201780087028.5, Office Action dated Aug. 25, 2022”, with English translation of claims, 10 pgs. |
“Chinese Application Serial No. 201780087028.5, Office Action dated Dec. 16, 2021”, with English translation of claims, 8 pgs. |
“Chinese Application Serial No. 201780087028.5, Response filed Jul. 7, 2022 to Office Action dated May 9, 2022”, w/ English Claims, 8 pgs. |
“European Application Serial No. 17707743.5, Intention to Grant dated Sep. 30, 2021”, 20 pgs. |
“European Application Serial No. 17707743.5, Response to Communication pursuant to Rules 161(1) and 162 EPC filed Mar. 24, 2020”, 20 pgs. |
“International Application Serial No. PCT/US2017/018787, International Preliminary Report on Patentability dated Sep. 6, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2017/018787, Written Opinion dated Oct. 26, 2017”, 6 pgs. |
“Japanese Application Serial No. 2019-546035, Notice of Reasons for Refusal filed Oct. 27, 2020”, with English translation of claims, 16 pgs. |
“Japanese Application Serial No. 2019-546035, Written Opinion filed Mar. 29, 2021”, with English translation, 12 pgs. |
Number | Date | Country | |
---|---|---|---|
20200008837 A1 | Jan 2020 | US |